TRLV · NYSE · CIK 0001754195

Trulieve Cannabis Corp.

Trulieve Cannabis Corp.’s most recent SEC filing in our snapshot is a Form S-8 POS filed on Aug 24, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $1.2B and net income of -$122.2M, according to its XBRL data on EDGAR. Its EDGAR record lists 26 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$1.2B
Net income, FY2025
-$122.2M
Form 4 filings on record, past 12 months
26

Company overview

Legal name (as filed)
Trulieve Cannabis Corp.
Ticker
TRLV
SEC Central Index Key (CIK)
0001754195
Business address
TALLAHASSEE, FL
State or country of incorporation
British Columbia, Canada
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#1928 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Trulieve Cannabis Corp.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$931.9MFY2021$1.2BFY2022$1.1BFY2023$1.2BFY2024$1.2BFY2025
Net income
$17.4MFY2021-$252.7MFY2022-$533.1MFY2023-$160.6MFY2024-$122.2MFY2025
TRLV annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$931.9M$1.2B$1.1B$1.2B$1.2B
Net income$17.4M-$252.7M-$533.1M-$160.6M-$122.2M
Diluted EPS$0.21-$0.95-$2.28-$0.79-$0.58
Total assets$3.4B$3.4B$2.7B$2.9B$2.7B
Cash and equivalents$226.6M$207.2M$201.4M$238.8M$255.5M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

TRLV latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 26, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 7, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 11, 20268-KMaterial agreement; Unregistered equity sale; Change to shareholder rights; Charter, bylaws or fiscal year change· period Aug 11, 2026Document · Index
Jun 25, 2026DEF 14ADefinitive proxy statement· period Jun 25, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Trulieve Cannabis Corp., by form type:

4 ×168-K ×1010-Q ×2DEFA14A ×2DEF 14A ×2144 ×1S-8 POS ×1POSASR ×1SCHEDULE 13G ×1PRE 14A ×18-A12B ×1CERT ×1ARS ×1
TRLV recent filings
FiledFormWhat it isOriginal
Aug 24, 2026S-8 POSS-8 POSDocument · Index
Aug 24, 2026POSASRPOSASRDocument · Index
Aug 11, 20268-KMaterial agreement; Unregistered equity sale; Change to shareholder rights; Charter, bylaws or fiscal year change· period Aug 11, 2026Document · Index
Aug 7, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 7, 20268-KAcquisition or disposition completed; Regulation FD disclosure· period Aug 7, 2026Document · Index
Aug 5, 20268-KShareholder vote results· period Aug 5, 2026Document · Index
Jul 8, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jul 2, 20268-KDirector or officer change· period Jun 30, 2026Document · Index
Jun 26, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 26, 2026Document · Index
Jun 25, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Jun 25, 2026DEF 14ADefinitive proxy statement· period Jun 25, 2026Document · Index
Jun 25, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 17, 2026Document · Index
Jun 17, 2026144Notice of proposed sale of securitiesDocument · Index
Jun 12, 2026PRE 14APRE 14A· period Jun 8, 2026Document · Index
Jun 12, 20268-KDirector or officer change· period Jun 11, 2026Document · Index
Jun 11, 20268-KShareholder vote results· period Jun 9, 2026Document · Index
Jun 9, 20268-KOther events· period Jun 9, 2026Document · Index
Jun 9, 20268-A12B8-A12BDocument · Index
Jun 9, 2026CERTNYSE CERTIFICATIONDocument · Index
Jun 4, 20268-KMaterial agreement; Acquisition or disposition completed· period Jun 3, 2026Document · Index
May 7, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 7, 20268-KResults of operations; Regulation FD disclosure· period May 7, 2026Document · Index
Apr 29, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Apr 29, 2026ARSARS· period Dec 31, 2025Document · Index
Apr 29, 2026DEF 14ADefinitive proxy statement· period Dec 31, 2025Document · Index
Apr 21, 20268-KDirector or officer change· period Apr 15, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 3, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index

Insider filing activity

26 Form 4 filings appear in Trulieve Cannabis Corp.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Medicinal Chemicals & Botanical Products

All 6 companies in Medicinal Chemicals & Botanical Products· Companies headquartered in Florida

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001754195 and XBRL company facts. Trulieve Cannabis Corp. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.